关键词: Accountability Maximum allowable failures Monitoring

Mesh : Humans Licensure, Pharmacy Education, Pharmacy / standards Educational Measurement / standards methods statistics & numerical data Accreditation / standards Pharmacists / standards statistics & numerical data Schools, Pharmacy / standards statistics & numerical data United States North America Students, Pharmacy

来  源:   DOI:10.1016/j.ajpe.2024.100723

Abstract:
From 2021 to 2023, 7978 graduates of pharmacy programs failed the North American Pharmacist Licensure Examination on the first attempt. Presently, the Accreditation Council for Pharmacy Education monitors programs with a passage rate of ≥ 2 SDs below the national mean pass rate. In 2023, this should lead to monitoring 7 programs that produced 140 failures out of the total of 2472 failures (5.7 %). In our view, this is neither equitable nor demonstrative of sufficient accountability. Analysis of failure counts among the 144 programs reported by the National Association of Boards of Pharmacy demonstrates a distribution curve highly skewed to the right. The evaluation of average failure counts across all programs suggests that schools with absolute failures ≥ 2 SDs higher than the average number of failures should be identified for monitoring, in addition to those falling ≥ 2 SDs below the national mean pass rate. Based on the 2023 data, this additional criterion corresponds to ≥ 35 failures/program. This threshold would prompt monitoring of 18 programs and 36.5 % of the total failures. Of the 7 programs that will be monitored based on the current Accreditation Council for Pharmacy Education criteria, only 1 would be captured by the ≥ 35 failure method of selection; the remaining 6 contribute 85 total failures to the pool. Thus, if both criteria were to be applied, ie, ≥ 35 failures and ≥ 2 SDs below the national mean pass rate, a total of 24 programs would be monitored (16.6 % of the 144 programs) that contribute 987 of the total failures (39.9 %).
摘要:
从2021年到2023年,7,978名药学课程毕业生在第一次尝试中未能通过北美药剂师执照考试(NAPLEX®)。目前,药学教育认证委员会(ACPE)对通过率低于全国平均通过率≥2个标准差(SD)的项目进行监测.到2023年,这将导致监测七个程序,这些程序在总共2,472个故障中产生140个故障(5.7%)。在我们看来,这既不是公平的,也不是足够的问责制。美国国家药房协会(NABP)报告的144个计划中的失败计数分析显示,分布曲线高度向右倾斜。对所有课程的平均失败计数的评估表明,应确定绝对失败≥2SD高于平均失败数的学校进行监控,除了那些低于全国平均合格率≥2SD的人。根据2023年的数据,此附加标准对应于≥35个故障/程序。此阈值将提示监视18个程序和总故障的36.5%。在将根据当前的ACPE标准进行监控的七个程序中,≥35故障选择方法只会捕获一个;其余六个为池贡献85个总故障。因此,如果这两个标准都适用,即,≥35次不合格,低于全国平均合格率≥2个标准差,总共将监测24个节目(144个节目中的16.6%),占总故障的987(39.9%)。
公众号